| | Variable | Hospital days | | 1st | 3rd | 6th | 10th | 14th | 20th |
| | General appearance | Ill | Toxic | Toxic | Mildly ill | Fair | Good |
| | Fever | Yes | Yes | Yes | No | No | No |
| | Rash | Yes | Yes | Yes | Yes | No | No |
| | Tachypnea | No | Yes | Yes | Yes | No | No |
| | Hypotension | No | No | Yes | No | No | No |
| | Total white blood cell count, ×106/L | 22,000 | 21,800 | 27,000 | 28,300 | 25,700 | 21,880 |
| | Neutrophil, % | 83 | 79 | 79 | 72 | 38 | 57 |
| | Lymphocyte, % | 5 | 15 | 10 | 11 | 44 | 30 |
| | Monocyte, % | 3 | 1 | 10 | 14 | 17 | 7 |
| | Hemoglobin, g/L | 10.6 | 8.7 | 10 | 11.9 | 11.7 | 11.4 |
| | Platelet count, ×106/L | 197,000 | 224,000 | 420,000 | 863,000 | 1,168,000 | 964,000 |
| | ESR | 65 | — | 75 | 72 | 25 | 3 |
| | CRP, mg/L | 38 | — | 38 | 25 | 10 | 29 |
| | AST, mg/dl | 200 | 55 | 42 | — | 38 | — |
| | ALT, mg/dl | 197 | 57 | 35 | — | 32 | — |
| | Antibiotic(s) | Cefotaxime | Meropenem, vancomycin | Meropenem, vancomycin | Meropenem | Meropenem | — |
| | Daily main changes in medications | (i) IVIG (1st) 2 gr/kg (ii) ASA 15 mg/kg/q6h (iii) Albumin 1 g/kg/day for 3 days (iv) Hydroxychloroquine 5 mg/kg/day for 5 days | (i) IVIG (2nd) 2 gr/kg (ii) Packed RBC transfusion 10 ml/kg (iii) Captopril 0.3 mg/kg/q8h for 3 days (iv) Fresh frozen plasma 10 ml/kg | (i) Prednisolone 2 mg/kg/day (ii) Dopamine 6 micg/kg/min (iii) Milrinone 0.5 micg/kg/min (iv) Packed RBC transfusion 10 ml/kg (v) Albumin 1 g/kg/day for 3 days | (i) Clopidogrel 0.5 mg/kg/day continued until discharge (ii) Captopril 0.3 mg/kg/q8h | (i) Prednisolone tapered (ii) Heparin 10–20 U/kg/h for 3 days (iii) ASA 5 mg/kg/day continued until discharge | (i) Warfarin 0.1 mg/kg/day started from the 16th day and continued until discharge (ii) Infliximab 5 mg/kg on the 19th day |
| | Echocardiography | Minimal MR, normal coronary arteries, good LVEF | Mild to moderate MR, TR and PI, mild coronary dilatation in LAD and LCX, diastolic dysfunction, good LVEF | Moderate MR and TR, ectatic coronary arteries, mild diastolic dysfunction, LVEF: 43% | Minimal MR, mild TR and PI, moderate aneurysmal coronary artery: RCA: 5.8 mm, LMCA: 6.2, LAD: 5.9, LVEF: 62% | Minimal MR, mild TR, minimal PI, dilated aneurysmal RCA: 7.8 mm, LMCA: 7.7 mm, LAD: 5.7 mm, good LVEF | Minimal MR, no TR, minimal PI, giant aneurysms in RCA: 8.3 mm, LMCA: 7.7 mm, LAD: 7.3 mm, good LVEF |
|
|